Clinical Trial Update: Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Exploratory Phase 2 clinical study evaluating apatinib in combination with a PD-1 inhibitor for advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Advanced Gastric Cancer | Phase 2 | Status: UNKNOWN